A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)
Clinical trial NCT04624659 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04624659
- Sponsor
- Forma Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-29
- Primary completion
- 2026-02-06
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.